IRLCF (The Israel) YoY EBITDA Growth: 14.81% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IRLCF The Israel Corp Ltd IRLCF
67 GF Score
Price $27.91
GF Value $31.17
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is The Israel YoY EBITDA Growth?

The Israel IRLCF 67 YoY EBITDA Growth is 14.81% as of Mar. 2026. GuruFocus rates IRLCF with a GF Score™ of 67/100 and a GF Value™ of $31.17 (Modestly Undervalued). The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. The Israel's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 14.81%.

The Israel's EBITDA per Share for the three months ended in Mar. 2026 was $5.76.

The Israel YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for The Israel's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Israel YoY EBITDA Growth Chart

The Israel Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.07 110.71 -58.03 -14.98 -6.18

The Israel Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.46 -1.04 20.84 -56.22 14.81
IRLCF
67GF Score
The Israel Corp Ltd IRLCF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Israel YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

The Israel's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(17.829-19.004)/ | 19.004 |
=-6.18 %

The Israel's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(5.76-5.017)/ | 5.017 |
=14.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 14.81% mean?
The Israel (IRLCF) has a YoY EBITDA Growth of 14.81% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for The Israel and its competitors.
Is The Israel's YoY EBITDA Growth too high?
The Israel's current YoY EBITDA Growth is 14.81%. Overall, The Israel has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Israel's YoY EBITDA Growth compare to LIN and SHW?
The Israel's YoY EBITDA Growth of 14.81% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Chemicals company?
A good YoY EBITDA Growth depends on the Chemicals industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for The Israel and its competitors. The Israel's current YoY EBITDA Growth is 14.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
Based on GuruFocus' analysis, The Israel (IRLCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.17, compared to a current price of $27.91 — trading 10.5% below its estimated fair value. The current YoY EBITDA Growth is 14.81%. The Israel's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For The Israel (IRLCF), the current YoY EBITDA Growth is 14.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Israel (IRLCF) Overvalued in 2026?

Based on GuruFocus' analysis, The Israel stock appears to be undervalued. The current stock price of $27.91 is trading 10.5% below its estimated GF Value™ of $31.17. GuruFocus considers The Israel to be Modestly Undervalued.

Key valuation signals for IRLCF:

  • YoY EBITDA Growth: 14.81%
  • GF Value™: $31.17 vs. price of $27.91 (10.5% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the IRLCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Israel Business Description

Other Exchanges ILCO:Israel
Address 23 Aranha Street, P.O. Box 20456, Millennium Tower, Tel Aviv, ISR, 61204
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
67GF Score

Get the complete analysis for IRLCF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.91
Price
$31.17
GF Value